Found 486 bookmarks
Newest
If you don't test, they will not treat: Impact of stopping preoperative screening for asymptomatic bacteriuria - PubMed
If you don't test, they will not treat: Impact of stopping preoperative screening for asymptomatic bacteriuria - PubMed
Removal of urinalysis and urine culture from preoperative checklists for cardiac surgery led to a statistically significant decrease in testing without an increase in SSIs, CLABSIs, CAUTIs, or CDI. Challenges identified included persistence of checklists in templated order sets in the electronic hea …
·pubmed.ncbi.nlm.nih.gov·
If you don't test, they will not treat: Impact of stopping preoperative screening for asymptomatic bacteriuria - PubMed
Mandatory ID approval associated with improved C. difficile testing
Mandatory ID approval associated with improved C. difficile testing
An intervention requiring that infectious diseases approve testing for Clostridioides difficile infection increased the appropriateness of testing for hospital-onset C. difficile and lowered the positive testing rate by more than 50%.
·news.google.com·
Mandatory ID approval associated with improved C. difficile testing
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for Clostridioides difficile in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT - PubMed
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for Clostridioides difficile in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT - PubMed
Clostridioides difficile infection (CDI) is a major healthcare-associated infection that leads to a significant health economic burden in Japan. Using a decision tree model, we evaluated the budget impact of adopting a one-step nucleic acid amplification test (NAAT) alone pathway compared to …
·pubmed.ncbi.nlm.nih.gov·
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for Clostridioides difficile in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT - PubMed
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for Clostridioides difficile in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT - PubMed
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for Clostridioides difficile in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT - PubMed
Clostridioides difficile infection (CDI) is a major healthcare-associated infection that leads to a significant health economic burden in Japan. Using a decision tree model, we evaluated the budget impact of adopting a one-step nucleic acid amplification test (NAAT) alone pathway compared to …
·pubmed.ncbi.nlm.nih.gov·
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for Clostridioides difficile in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT - PubMed
Testing policy change could reduce the burden of C. diff infections
Testing policy change could reduce the burden of C. diff infections
A new study published today in the American Journal of Infection Control suggests that allowing bedside nurses to independently order testing for C. difficile significantly decreased the amount of time to receive test results as compared to requiring physician approval.
·news.google.com·
Testing policy change could reduce the burden of C. diff infections
The case for letting nurses initiate C. diff testing
The case for letting nurses initiate C. diff testing
Allowing nurses to order Clostridioides difficile testing without a physician's approval could help hospitals lower infection rates, a new study suggests.
·news.google.com·
The case for letting nurses initiate C. diff testing
Impact of Mandatory Infectious Disease Specialist Approval on Hospital-Onset Clostridioides difficile Infection Rates and Testing Appropriateness - PubMed
Impact of Mandatory Infectious Disease Specialist Approval on Hospital-Onset Clostridioides difficile Infection Rates and Testing Appropriateness - PubMed
An infectious disease-led C. difficile testing approval process was feasible and associated with a 50% decrease in HO-CDI rates, due to enforcement of appropriate testing.
·pubmed.ncbi.nlm.nih.gov·
Impact of Mandatory Infectious Disease Specialist Approval on Hospital-Onset Clostridioides difficile Infection Rates and Testing Appropriateness - PubMed
A comparison of culture methods and polymerase chain reaction in detecting Clostridioides difficile from hospital surfaces
A comparison of culture methods and polymerase chain reaction in detecting Clostridioides difficile from hospital surfaces
Introduction. Environmental surveillance for Clostridioides difficile is challenging. There are no internationally agreed recommendations on which method should be used when environmental surveillance is undertaken. Aim. To compare the detection of C. difficile by RT-PCR to culture-based methods and to determine which is more sensitive and specific in the clinical environment. Methods. Forty-four near-patient areas of C. difficile -positive patients were sampled using contact plates and moistened flocked swabs. Results. Detection using moistened flocked swabs followed by RT-PCR or culture detected more C. difficile than contact plates. The sensitivity and specificity of a RT-PCR assay for tcdB compared to the culture methods was 76 and 91 %, respectively. Conclusion. Despite the lower sensitivity and specificity, RT-PCR could potentially offer a more rapid and practical alternative.
·microbiologyresearch.org·
A comparison of culture methods and polymerase chain reaction in detecting Clostridioides difficile from hospital surfaces
Diagnosis of C difficile Infection (CDI)
Diagnosis of C difficile Infection (CDI)
Joseph Reilly, BS, PharmD, BCGP; Candace Cotto, RN; and Andrew Skinner, MD, review C. difficile infection (CDI), its risk factors, symptoms, and quality of life for the patient.
·news.google.com·
Diagnosis of C difficile Infection (CDI)
An Algorithm Addressing the Problem of Overdiagnoses of Clostridioides difficile Infections in Hematopoietic Stem-Cell Transplant Recipients: Effects on CDI Rates and Patient Outcomes - PubMed
An Algorithm Addressing the Problem of Overdiagnoses of Clostridioides difficile Infections in Hematopoietic Stem-Cell Transplant Recipients: Effects on CDI Rates and Patient Outcomes - PubMed
Use of an algorithm defining criteria for C. difficile testing, diagnosis, and treatment was associated with significantly decreased CDI diagnoses on a HSCT inpatient unit without apparent adverse effects.
·pubmed.ncbi.nlm.nih.gov·
An Algorithm Addressing the Problem of Overdiagnoses of Clostridioides difficile Infections in Hematopoietic Stem-Cell Transplant Recipients: Effects on CDI Rates and Patient Outcomes - PubMed
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-20201 - PubMed
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-20201 - PubMed
Although Clostridioides difficile infection (CDI) incidence is high in the United States, standard-of-care (SOC) stool collection and testing practices might result in incidence overestimation or underestimation. We conducted diarrhea surveillance among inpatients 50 years of age in Louisville, …
·pubmed.ncbi.nlm.nih.gov·
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-20201 - PubMed
2-Steps-Are-Better-Than-1-for-CDI-Testing
2-Steps-Are-Better-Than-1-for-CDI-Testing
A-two-step-algorithm-for-Clostridioides-difficile-infection-CDI-testing-may-reduce-unnecessary-treatment-and-improve-detection-according-to-data-presented-at
·idse.net·
2-Steps-Are-Better-Than-1-for-CDI-Testing
Prof. Fidelma Fitzpatrick on Twitter
Prof. Fidelma Fitzpatrick on Twitter
Excellent presentation @kerrieanndavies @ESCMID #ECCMID23 #ECCMID2023 lactoferrin may help tease out the significance of GDH positive /EIA negative #cdiff samples - 40min turn around - quantitative version pic.twitter.com/6J05b12NEN— Prof. Fidelma Fitzpatrick (@FfitzP) April 18, 2023
·twitter.com·
Prof. Fidelma Fitzpatrick on Twitter
Bug Pharmacist 💊🧫 Tim Gauthier on Twitter
Bug Pharmacist 💊🧫 Tim Gauthier on Twitter
So proud of our former ID PGY2 (and 🦸‍♀️super steward) @LinezoLiv who just presented one of her residency projects here at #ECCMID2023 finding a two-step method for C diff testing led to a reduction in unnecessary treatment 🙌 #Cdiff #DiagnosticStewardship #IDtwitter pic.twitter.com/9eUH3iOS34— Bug Pharmacist 💊🧫 Tim Gauthier (@IDstewardship) April 15, 2023
·twitter.com·
Bug Pharmacist 💊🧫 Tim Gauthier on Twitter
Clostridium Diagnostics Market in the United Kingdom is expected to be worth US$ 330 million by 2032
Clostridium Diagnostics Market in the United Kingdom is expected to be worth US$ 330 million by 2032
The global Clostridium Diagnostics Market is anticipated to grow at a 12.2% CAGR from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market saw a 13.6% CAGR between 2015 and 2021. The market is expanding as a result of increased awareness-raising activities for clostridium-related ill...
·news.google.com·
Clostridium Diagnostics Market in the United Kingdom is expected to be worth US$ 330 million by 2032
Clostridium Diagnostics Market is expected to reach a valuation of US$ 7.8 Billion by 2032 | FMI Analyst - FMIBlog
Clostridium Diagnostics Market is expected to reach a valuation of US$ 7.8 Billion by 2032 | FMI Analyst - FMIBlog
The global Clostridium Diagnostics Market is anticipated to grow at a 12.2% CAGR from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market saw a 13.6% CAGR between 2015 and 2021. The market is expanding as a result of increased awareness-raising activities for clostridium-related illnesses and their rising prevalence. There has been an increased focus of […]
·news.google.com·
Clostridium Diagnostics Market is expected to reach a valuation of US$ 7.8 Billion by 2032 | FMI Analyst - FMIBlog